Purity >95%, by SDS-PAGE under reducing conditions and visualized by silver stain. MW (observed): 61-75 kDa, reducing conditions. MW (theoretical): 36.0 kDa. The Recombinant Human CD55/DAF Protein from R&D Systems is derived from NS0. The Recombinant Human CD55/DAF Protein has been validated for the following applications: Binding Activity.
Size
50 ug
Concentration
n/a
Applications
Binding Activity
Other Names
CD55, CD55 antigen, CD55 molecule, decay accelerating factor for complement (Cromer blood group), CR, CRdecay accelerating factor for complement (CD55, Cromer blood group system), CROMDAFcomplement decay-accelerating factor, DAF, decay accelerating factor for complement, TC